Integra Lifesciences Holdings Corp
IART· Nasdaq
IARTIntegra Lifesciences Holdings Corp
Source filing unavailable
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $193.33M | $178.60M | $165.73M |
| Net Income | $699.00K | $15.16M | $11.23M |
| EPS Diluted | $0.02 | $0.50 | $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
